![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » FDA Lays Out Possible LDT Oversight Approach
FDA Lays Out Possible LDT Oversight Approach
![FDA_Logo_Blue_2016.gif](https://www.fdanews.com/ext/resources/test/Drug-Images4/FDA_Logo_Blue_2016.gif?t=1578316591&width=430)
After spending months analyzing more than 300 comments on its draft laboratory developed test guidance, the FDA punted the issue to allow more public discussion and a possible legislative solution rather than making the controversial guidance final.
In a discussion paper, the FDA outlined a possible approach that would focus on new and significantly modified high- and moderate-risk LDTs.
The agency acknowledged that there is a growing consensus that additional oversight of LDTs is needed, as reflected in several proposals from organizations representing laboratories and the IVD industry. — Jeff Kinney
Upcoming Events
-
11Jul
-
18Jul
-
21Oct